Correlia Biosystems is based at the University of California at Berkeley, and develops novel microfluidic tools that are cost-efficient, rapid, and customizable. Their versatile SimpleScan technology has point-of-care applications ranging from STD diagnostics to allergen screening. Pain: Patients seeking confirmatory diagnosis of infectious disease can wait days or weeks for results from slow, labor-intensive, and costly laboratory equipment. Solution: SimpleScan technology provides a platform to deliver rapid, inexpensive, and accurate point-of-care tests of co-infection (e.g. HIV/HCV), permitting doctors to make immediate and informed treatment decisions.